<DOC>
	<DOC>NCT02845843</DOC>
	<brief_summary>This is a placebo-controlled clinical trial to assess the feasibility, efficacy and safety of a combination of lopinavir/ritonavir and Interferon beta-1b in hospitalized patients with MERS.</brief_summary>
	<brief_title>MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b</brief_title>
	<detailed_description>The aim of this study is to investigate the feasibility , efficacy and safety of lopinavir /ritonavir and recombinant Interferon beta-1b combination given with optimal supportive care compared to placebo with optimal supportive care for patients with laboratory-confirmed MERS-CoV infection requiring hospital admission.</detailed_description>
	<mesh_term>Coronavirus Infections</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Interferon beta-1b</mesh_term>
	<criteria>Inclusion criteria: 1. All patients who are laboratory confirmed (RTPCR) MERSCoV and require hospital admission because of illness severity. 2. More than or equal to 18 years of age. Exclusion criteria: 1. History of acute severe neuropsychiatric disorder such as schizophrenia etc. 2. History of hypersensitivity reaction to lopinavir /ritonavir, or any component of the formulation and to recombinant interferon beta1b (e.g., toxic epidermal necrolysis, StevensJohnson syndrome, erythema multiforme, urticaria, angioedema) 3. Fulminant liver failure 4. Patients on medications which are contraindicated with the study drug and cannot be replaced or stopped during the study period (e.g Cytochrome P450 3A4 (CYP3A) inhibitors)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Middle East Respiratory Syndrome Coronavirus</keyword>
	<keyword>MERS-CoV</keyword>
	<keyword>Clinical trial</keyword>
	<keyword>Lopinavir</keyword>
	<keyword>Ritonavir</keyword>
	<keyword>Interferon beta</keyword>
</DOC>